Folliculitis — inflammation of the hair follicle — is a common skin condition that many people worry may lead to lasting hair loss. In most cases, mild folliculitis causes only temporary shedding that resolves once the infection clears. However, certain subtypes, particularly those that cause scarring, can permanently destroy hair follicles if left untreated. Understanding the difference between superficial and deep or chronic forms is essential for protecting long-term hair density. This article explains how folliculitis affects the follicle, which types carry the greatest risk, how diagnosis is made, and what treatments are available on the NHS.

How Folliculitis Affects the Hair Follicle

Folliculitis disrupts the hair growth cycle through inflammation, but superficial cases cause only temporary shedding; permanent loss occurs only when deep or chronic infection destroys the follicular stem cell niche in the bulge region.

Folliculitis is an inflammatory condition of the hair follicle, most commonly caused by bacterial infection — particularly Staphylococcus aureus — though fungal, viral, and non-infectious causes also exist. When a follicle becomes inflamed, the normal cycle of hair growth can be disrupted, leading to temporary shedding or thinning in the affected area. In most mild cases, this hair loss is entirely reversible once the infection resolves; superficial disease typically causes temporary telogen shedding or broken hairs rather than destruction of the follicle itself.

Not sure if this is normal? Chat with one of our pharmacists →

The hair follicle is a complex, metabolically active structure responsible for producing and anchoring the hair shaft. Inflammation introduces pro-inflammatory cytokines and immune cells into the follicular environment, which can interfere with the anagen (growth) phase of the hair cycle. Crucially, superficial and short-lived inflammation does not damage the follicular stem cell niche (located in the bulge region), so the follicle typically recovers fully. However, when infection penetrates deeper into the dermis or becomes chronic, the structural integrity of the follicle itself may be compromised.

It is important to understand that not all folliculitis leads to hair loss, and the relationship between the two depends heavily on:

• The depth and severity of the inflammation

• The causative organism or trigger

• How promptly and effectively treatment is initiated

• Whether scarring occurs as part of the healing process

For most patients, folliculitis presents as small, red, pustular spots around hair follicles — commonly on the scalp, beard area, thighs, or buttocks. Mild cases often resolve with basic hygiene measures and topical treatments, leaving no lasting impact on hair density.

It is also worth noting that not all follicular inflammation is infectious. Pseudofolliculitis barbae — a non-infectious condition caused by ingrown hairs, most commonly in the beard area — can mimic bacterial folliculitis but does not typically cause permanent hair loss. Distinguishing between infectious and non-infectious causes is important for guiding appropriate management.

For general information on folliculitis, the NHS website and British Association of Dermatologists (BAD) patient information leaflets are reliable UK patient-facing resources.

Types of Folliculitis Most Linked to Permanent Hair Loss

Folliculitis decalvans, dissecting cellulitis of the scalp, folliculitis keloidalis nuchae, and kerion are the subtypes most strongly associated with permanent, scarring hair loss due to destruction of follicular stem cells.

Whilst superficial folliculitis rarely causes lasting damage, several specific subtypes are strongly associated with permanent or scarring hair loss (known clinically as cicatricial alopecia). These conditions destroy the follicular stem cells located in the bulge region of the follicle, making regrowth impossible once scarring has occurred.

Folliculitis decalvans is one of the most clinically significant forms. It is a chronic, neutrophilic scarring alopecia predominantly affecting the scalp, characterised by recurring crops of pustules, crusting, and progressive bald patches with a distinctive tufted appearance — where multiple hairs emerge from a single follicular opening. The exact cause remains unclear, though S. aureus is frequently implicated as a trigger. The BAD provides dedicated patient information on this condition.

Dissecting cellulitis of the scalp (also called perifolliculitis capitis abscedens et suffodiens) is another destructive condition, more common in men of African or Afro-Caribbean ancestry. It involves deep, interconnecting abscesses and nodules that, over time, lead to significant scarring and permanent hair loss. BAD patient information is available for this condition.

Folliculitis keloidalis nuchae (also known as acne keloidalis nuchae) is a scarring folliculitis affecting the nape of the neck, most commonly in men of African or Afro-Caribbean ancestry. It presents with firm papules and plaques that can progress to keloid-like scarring and permanent hair loss in the affected area. The Primary Care Dermatology Society (PCDS) provides guidance on this condition.

Kerion — a severe, inflammatory form of tinea capitis (scalp ringworm) — is an important and potentially urgent cause of scarring hair loss, particularly in children. It presents as a tender, boggy, pustular plaque on the scalp and requires prompt systemic antifungal treatment to prevent permanent follicular destruction. Delayed treatment significantly increases the risk of irreversible scarring. The NHS tinea capitis page and NICE Clinical Knowledge Summary (CKS) on fungal scalp infection provide further guidance.

Eosinophilic folliculitis, though less common in the UK general population, is seen in immunocompromised individuals — particularly those living with HIV. Whilst it is primarily a pruritic condition, some patients may experience hair changes in affected areas; however, it is not a defining cause of significant hair loss and any such association should be assessed on an individual basis.

By contrast, hot tub folliculitis (caused by Pseudomonas aeruginosa) and Malassezia (pityrosporum) folliculitis (a fungal variant) are generally non-scarring and do not typically cause permanent hair loss. Recognising which subtype is present is therefore clinically essential, as the prognosis and management differ considerably between scarring and non-scarring forms.

Diagnosing Folliculitis and Associated Hair Thinning

Diagnosis begins with clinical assessment; skin swabs, mycological testing, dermoscopy, and scalp biopsy may be needed — biopsy is the gold standard for confirming scarring folliculitis.

Accurate diagnosis is the cornerstone of effective management. A GP will usually begin with a thorough clinical history and physical examination, assessing the distribution, morphology, and duration of lesions, alongside any associated symptoms such as itching, pain, or systemic features. The pattern of hair loss — whether patchy, diffuse, or associated with scarring — provides important diagnostic clues.

In straightforward cases, diagnosis is clinical. However, where the cause is uncertain or the condition is not responding to initial treatment, further investigations may be warranted:

• Skin swabs for bacterial culture and sensitivity testing, to identify the causative organism and guide antibiotic choice

• Skin scrapings or hair samples for mycological examination if a fungal cause (such as tinea capitis) is suspected — this is particularly important in children presenting with scalp hair loss

• Dermoscopy, a non-invasive technique increasingly used in primary and secondary care, can help differentiate scarring from non-scarring alopecia and identify follicular changes characteristic of specific subtypes

• Scalp biopsy remains the gold standard for diagnosing scarring folliculitis, providing histological evidence of fibrosis, follicular destruction, and the nature of the inflammatory infiltrate

Blood tests are not routinely required for uncomplicated folliculitis but may be considered if an underlying immunodeficiency (such as HIV or haematological conditions), poorly controlled diabetes, or immunosuppressive therapy is suspected as a contributing factor.

In children presenting with a tender, boggy scalp plaque and hair loss, kerion should be considered urgently, as prompt systemic antifungal treatment is required to prevent permanent scarring. This warrants same-day or urgent assessment.

For recurrent staphylococcal folliculitis, it is worth considering whether the patient or close contacts may be carriers of S. aureus; decolonisation strategies (such as nasal mupirocin ointment and chlorhexidine body washes) may be appropriate in line with UKHSA guidance and local protocols.

NICE CKS guidance on fungal scalp infection and NICE guideline NG141 on cellulitis and erysipelas (antimicrobial prescribing) provide UK-specific recommendations on investigation and management. PCDS guidance on scarring alopecia also outlines referral thresholds and biopsy indications. A stepwise approach is recommended, with referral to dermatology when the diagnosis is uncertain, when scarring alopecia is suspected, or when first-line treatments have failed. Early and accurate diagnosis is particularly important in scarring subtypes, where delays can result in irreversible follicular loss.

Treatment Options Available on the NHS

NHS treatment is guided by cause and severity, ranging from topical antiseptics for mild bacterial cases to specialist-led oral antibiotics or isotretinoin for scarring subtypes; hair lost to scarring cannot be regrown.

Treatment for folliculitis on the NHS is guided by the underlying cause, severity, and whether scarring is present. For mild, non-scarring bacterial folliculitis, first-line management typically involves:

• Topical antiseptic washes such as chlorhexidine or benzoyl peroxide, which are preferred as initial treatment to reduce bacterial load whilst minimising antibiotic resistance

• Topical antibiotics such as fusidic acid or mupirocin may be considered where S. aureus is confirmed or strongly suspected, but should be limited to short courses (typically no longer than one to two weeks) to reduce the risk of resistance; mupirocin should be reserved and not used routinely, in line with antimicrobial stewardship principles

• Advice on avoiding shaving the affected area, using clean towels, and not sharing personal hygiene items

Where topical measures are insufficient, or in more widespread or recurrent cases, oral antibiotics may be prescribed. Flucloxacillin is the first-line choice for staphylococcal infections in the UK; erythromycin or clarithromycin may be used in penicillin-allergic patients. Antibiotic choice should be guided by culture and sensitivity results where available.

For recurrent staphylococcal folliculitis, decolonisation with nasal mupirocin ointment and chlorhexidine washes (for the patient and, where appropriate, household contacts) should be considered in accordance with UKHSA guidance and local protocols.

For fungal folliculitis, treatment depends on the causative organism:

• Malassezia (pityrosporum) folliculitis often responds to topical antifungals such as ketoconazole shampoo or cream; oral itraconazole may be used in more extensive or refractory cases

• Tinea capitis (including kerion) requires systemic antifungal therapy. In adults, oral terbinafine is generally preferred for Trichophyton species; griseofulvin remains an option, particularly in children or where Microsporum species are involved. Antifungal choice should be guided by mycological results and NICE CKS guidance on fungal scalp infection. Suspected kerion requires urgent treatment to prevent scarring

Managing the scarring subtypes — such as folliculitis decalvans — is considerably more complex and requires specialist dermatological input. Treatment regimens may include:

• Long-term combination oral antibiotics (e.g., rifampicin with clindamycin) to suppress the chronic inflammatory cycle. These regimens are typically initiated and monitored by a dermatologist; rifampicin has significant drug interactions and both agents carry risks (including Clostridioides difficile infection with clindamycin) that require careful assessment

• Topical or intralesional corticosteroids to reduce inflammation and slow scarring progression

• Isotretinoin in selected cases, particularly for dissecting cellulitis of the scalp. Isotretinoin is a specialist-initiated treatment, often used off-label in this context, and requires careful monitoring. In women of childbearing potential, it must only be prescribed within the MHRA Pregnancy Prevention Programme (PPP), which mandates effective contraception and regular pregnancy testing. Prescribers and patients should refer to the current MHRA Drug Safety Update and the relevant Summary of Product Characteristics (SmPC) for full safety information

• Biologics or immunosuppressants may be considered in refractory cases under specialist supervision; these are off-label uses with a limited evidence base, and decisions should be made within a multidisciplinary or specialist dermatology setting

It is important to note that whilst treatment can halt progression and reduce symptoms, hair that has been lost due to scarring cannot be regrown, as the follicles are permanently destroyed. NHS funding for hair restoration procedures in scarring alopecia is not routinely commissioned and varies between Integrated Care Boards (ICBs); patients should discuss available options with their dermatologist or specialist team. Psychological support and counselling referral should also be considered where hair loss is causing significant distress.

For further information on specific treatments, the BAD patient information leaflets on folliculitis decalvans and dissecting cellulitis of the scalp, and the relevant MHRA/EMC SmPCs, are authoritative UK resources.

When to See a GP or Dermatologist

See a GP if folliculitis has not improved after two weeks, if hair thinning or bald patches develop, or if scarring alopecia is suspected — early referral to dermatology significantly limits permanent hair loss.

Many mild cases of folliculitis will resolve with over-the-counter antiseptic washes and good hygiene practices. However, there are clear circumstances in which prompt medical review is essential to prevent complications, including permanent hair loss.

Contact your GP if you notice any of the following:

• Folliculitis that has not improved after two weeks of self-care

• Spreading redness, swelling, or warmth around the affected area, which may suggest a deeper infection such as cellulitis or a carbuncle

• Pustules or nodules that are painful, large, or discharging

• Noticeable hair thinning or bald patches developing in or around the affected area

• Recurrent episodes of folliculitis, particularly on the scalp

• Systemic symptoms such as fever, fatigue, or swollen lymph nodes

• In children: a tender, boggy, or crusted scalp plaque with associated hair loss, which may indicate a kerion requiring urgent treatment

Seek same-day medical assessment if you develop rapidly spreading redness, significant swelling, fever, or feel generally unwell, as these may indicate a serious spreading infection requiring urgent treatment in line with NICE NG141 guidance on cellulitis.

Your GP may refer you to an NHS dermatologist if scarring alopecia is suspected, if the diagnosis is unclear, or if standard treatments have not been effective. Early referral is particularly important for conditions such as folliculitis decalvans and folliculitis keloidalis nuchae, where prompt specialist management can significantly limit the extent of permanent hair loss. Suspected kerion in a child should also prompt urgent referral or same-day assessment.

Patients who are immunocompromised — including those on long-term corticosteroids, immunosuppressants, or living with conditions such as diabetes or HIV — should seek medical advice sooner, as they are at greater risk of severe or atypical infections. Identifying and addressing any underlying risk factors is an important part of the overall assessment.

In summary, whilst folliculitis does not always cause hair loss, certain subtypes carry a genuine risk of permanent damage. Seeking timely medical advice, adhering to prescribed treatments, and attending follow-up appointments are the most effective ways to protect both scalp health and long-term hair density. The NHS website, BAD, and PCDS provide further patient-facing information and guidance on when to seek help.

Frequently Asked Questions